Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation

Article, Other literature type English OPEN
Mansor, Latt S. ; Mehta, Keshavi ; Aksentijevic, Dunja ; Carr, Carolyn A. ; Lund, Trine ; Cole, Mark A. ; Page, Lydia Le ; Sousa Fialho, Maria da Luz ; Shattock, Michael J. ; Aasum, Ellen ; Clarke, Kieran ; Tyler, Damian J. ; Heather, Lisa C. (2016)

Hypoxia activates the hypoxia-inducible factor (HIF), promoting glycolysis and suppressing mitochondrial respiration. In the type 2 diabetic heart, glycolysis is suppressed whereas fatty acid metabolism is promoted. The diabetic heart experiences chronic hypoxia as a consequence of increased obstructive sleep apnoea and cardiovascular disease. Given the opposing metabolic effects of hypoxia and diabetes, we questioned whether diabetes affects cardiac metabolic adaptation to hypoxia. Control and type 2 diabetic rats were housed for 3 weeks in normoxia or 11% oxygen. Metabolism and function were measured in the isolated perfused heart using radiolabelled substrates. Following chronic hypoxia, both control and diabetic hearts upregulated glycolysis, lactate efflux and glycogen content and decreased fatty acid oxidation rates, with similar activation of HIF signalling pathways. However, hypoxia-induced changes were superimposed on diabetic hearts that were metabolically abnormal in normoxia, resulting in glycolytic rates 30% lower, and fatty acid oxidation 36% higher, in hypoxic diabetic hearts than hypoxic controls. Peroxisome proliferator-activated receptor α target proteins were suppressed by hypoxia, but activated by diabetes. Mitochondrial respiration in diabetic hearts was divergently activated following hypoxia compared with controls. These differences in metabolism were associated with decreased contractile recovery of the hypoxic diabetic heart following an acute hypoxic insult. In conclusion, type 2 diabetic hearts retain metabolic flexibility to adapt to hypoxia, with normal HIF signalling pathways. However, they are more dependent on oxidative metabolism following hypoxia due to abnormal normoxic metabolism, which was associated with a functional deficit in response to stress.
  • References (13)
    13 references, page 1 of 2

    Lehman TC, Hale DE, Bhala A & Thorpe C. (1990). An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. Anal Biochem 186, 280-284.

    Mansor LS, Gonzalez ER, Cole MA, Tyler DJ, Beeson JH, Clarke K, Carr CA & Heather LC. (2013a). Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc Diabetol 12, 136-145.

    Mansor LS, Gonzalez ER, Cole MA, Tyler DJ, Beeson JH, Clarke K, Carr CA & Heather LC. (2013b). Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc Diabetol 12, 136.

    Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F & Giugliano D. (2002). Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45, 1172-1181.

    Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, Di Marino MP, Baldi A, Cuzzocrea S, Di Filippo C, Barboso G, Baldi F, Rossi F, D'Amico M & Giugliano D. (2004). Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 53, 2383-2391.

    Mayr M, Yusuf S, Weir G, Chung YL, Mayr U, Yin X, Ladroue C, Madhu B, Roberts N, De Souza A, Fredericks S, Stubbs M, Griffiths JR, Jahangiri M, Xu Q & Camm AJ. (2008). Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 51, 585- 594.

    Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T & Racineux JL. (2003). Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. The European respiratory journal 22, 156-160.

    Oakes ND, Thalen P, Aasum E, Edgley A, Larsen T, Furler SM, Ljung B & Severson D. (2006). Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. Am J Physiol Endocrinol Metab 290, E870-881.

    Park CW, Kim HW, Lim JH, Yoo KD, Chung S, Shin SJ, Chung HW, Lee SJ, Chae CB, Kim YS & Chang YS. (2009). Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice. Diabetes 58, 2666-2676.

    Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T & Gropler RJ. (2004). Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109, 2191- 2196.

  • Metrics
    No metrics available
Share - Bookmark